Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.671,38
0,13%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immuron Ltd (IMRN) Immuron Ltd (IMRN) Notizie

IMRN

Immuron (IMRN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMRN
DataOraFonteTitoloSimboloCompagnia
17/01/202514:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
17/01/202512:00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
15/01/202512:00GlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
14/01/202512:00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
06/12/202415:17GlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
06/12/202414:35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
02/12/202412:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
22/11/202400:33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
16/10/202412:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
04/10/202412:30GlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
01/10/202414:00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
05/09/202417:54GlobeNewswire Inc.Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewNASDAQ:IMRNImmuron Ltd
16/08/202412:00GlobeNewswire Inc.Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®NASDAQ:IMRNImmuron Ltd
07/08/202412:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct ConnectNASDAQ:IMRNImmuron Ltd
22/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMRNImmuron Ltd
15/07/202414:00GlobeNewswire Inc.Immuron announces record Travelan® sales globally, Australia and USANASDAQ:IMRNImmuron Ltd
02/07/202412:00GlobeNewswire Inc.Immuron requests pre-IND meeting for IMM-529 with FDA filingNASDAQ:IMRNImmuron Ltd
31/05/202412:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore to present at Peak Sky HighNASDAQ:IMRNImmuron Ltd
31/05/202412:00GlobeNewswire Inc.Immuron Board ChangesNASDAQ:IMRNImmuron Ltd
03/05/202412:00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
15/04/202412:00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
10/04/202412:00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
07/03/202412:00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
21/02/202412:00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
13/02/202412:00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
08/02/202412:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
16/01/202412:00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
22/12/202312:00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
04/12/202312:00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
14/11/202300:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMRN

La tua Cronologia

BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
BPSO
Banca Popolare di Sondrio
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci